Concepedia

Publication | Open Access

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

DOIFull Paper Access

496

Citations

31

References

2018

Year

Gina A. Montealegre Sanchez, Adam Reinhardt, Suzanne Ramsey, Helmut Wittkowski, Philip J. Hashkes, Yackov Berkun, Susanne Schalm, Sara Murías, Jason Dare, Diane E. Brown,
Journal of Clinical Investigation

Abstract

This research was supported by the Intramural Research Program of the NIH, NIAID, and NIAMS. Baricitinib was provided by Eli Lilly and Company, which is the sponsor of the expanded access program for this drug.

References

YearCitations

Page 1